Correlation Between Biotechnology Fund and Ultrasmall-cap Profund

Can any of the company-specific risk be diversified away by investing in both Biotechnology Fund and Ultrasmall-cap Profund at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biotechnology Fund and Ultrasmall-cap Profund into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Biotechnology Fund Class and Ultrasmall Cap Profund Ultrasmall Cap, you can compare the effects of market volatilities on Biotechnology Fund and Ultrasmall-cap Profund and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biotechnology Fund with a short position of Ultrasmall-cap Profund. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biotechnology Fund and Ultrasmall-cap Profund.

Diversification Opportunities for Biotechnology Fund and Ultrasmall-cap Profund

0.38

Correlation Coefficient

Biotechnology Fund  Ultrasmall-cap Profund

Weak diversification

The 3 months correlation between BIOTECHNOLOGY and Ultrasmall-cap is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Biotechnology Fund Class and Ultrasmall Cap Profund Ultrasm in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ultrasmall Cap Profund and Biotechnology Fund is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biotechnology Fund Class are associated (or correlated) with Ultrasmall-cap Profund. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ultrasmall Cap Profund has no effect on the direction of Biotechnology Fund i.e., Biotechnology Fund and Ultrasmall-cap Profund go up and down completely randomly.

Pair Corralation between Biotechnology Fund and Ultrasmall-cap Profund

Assuming the 90 days horizon Biotechnology Fund Class is expected to under-perform the Ultrasmall-cap Profund. But the mutual fund apears to be less risky and, when comparing its historical volatility, Biotechnology Fund Class is 1.54 times less risky than Ultrasmall-cap Profund. The mutual fund trades about 0.0 of its potential returns per unit of risk. The Ultrasmall Cap Profund Ultrasmall Cap is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  5,419  in Ultrasmall Cap Profund Ultrasmall Cap on October 10, 2024 and sell it today you would earn a total of  1,372  from holding Ultrasmall Cap Profund Ultrasmall Cap or generate 25.32% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Biotechnology Fund Class  vs.  Ultrasmall Cap Profund Ultrasm

Biotechnology Fund Class

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Biotechnology Fund Class has generated negative risk-adjusted returns adding no value to fund investors. In spite of weak performance in the last few months, the Fund's basic indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the fund investors.

Ultrasmall Cap Profund

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Ultrasmall Cap Profund Ultrasmall Cap are ranked lower than 2 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong forward indicators, Ultrasmall-cap Profund is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Biotechnology Fund and Ultrasmall-cap Profund

The main advantage of trading using opposite Biotechnology Fund and Ultrasmall-cap Profund positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biotechnology Fund position performs unexpectedly, Ultrasmall-cap Profund can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ultrasmall-cap Profund will offset losses from the drop in Ultrasmall-cap Profund's long position.

The idea behind Biotechnology Fund Class and Ultrasmall Cap Profund Ultrasmall Cap pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..